ClinicalTrials.gg
Drug

TGFB3 protein, human clinical trials

Also written Avotermin, Juvista and RN1001.

studies test it
18
open now
0
in phase 3
1
first study started
2001

How each study uses TGFB3 protein, human is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

TGF beta 3
3
Juvista (avotermin)
2
TGFbeta 3
2

Brand

Juvista
9

Development codes

RN1001
6
RN1006
1

Other names

Avotermin
13

Studies by the year they started

18 studies that test it; most in 2006 (4)

Studies that test TGFB3 protein, human, by start year
YearStudies
20012
20023
20033
20042
20064
20082
20092

By phase

A phase 1/2 study counts in both.

Phase 1
8
Phase 2
14
Phase 3
1
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 18 · Other 0

Renovo (18)

Studies

Open first, then newest update. How each study uses TGFB3 protein, human is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 18

Codes

What other systems call TGFB3 protein, human · ClinicalTrials.gg INT004887

  • MeSH (NLM) C509044TGFB3 protein, humanOne source NLM
  • UNII (FDA) 2Q1GS25JWNAVOTERMINConfirmed FDA, NLM
  • RxNorm 1427086One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.